Abstract

Background: Ultrasonography’s usefulness in endometrial cancer (EC) diagnosis consists in its roles in staging and prediction of metastasis. Ultrasound-measured tumor-free distance from the tumor to the uterine serosa (uTFD) is a promising marker for these diagnostic and prognostic variables. The aim of the study was to determine the usefulness of this biomarker in locoregional staging, and thus in the prediction of lymph node metastasis (LNM). Methods: We conducted a single-institutional, prospective study on 116 consecutive patients with EC who underwent 2D transvaginal ultrasound examination. The uTFD marker was compared with the depth of ultrasound-measured myometrial invasion (uMI). Univariable and multivariable logit models were evaluated to assess the predictive power of the uTFD and uMI in regard to LNM. The reference standard was a final histopathology result. Survival was assessed by the Kaplan–Meier method. Results: LNM was found in 17% of the patients (20/116). In the univariable analysis, uMI and uTFD were significant predictors of LNM. The accuracy was 70.7%, and the NPV was 92.68% (OR 4.746, 95% CI 1.710–13.174) for uMI (p = 0.002), and they were 63.8% and 89.02% (OR 0.842, 95% CI 0.736–0.963), respectively, for uTFD (p = 0.01). The cutoff value for uTFD in the prediction of LNM was 5.2 mm. The association between absence of LNM and biomarker values of uMI < 1/2 and uTFD ≥ 5.2 mm was greater than that between the presence of metastases and uMI > 1/2 and uTFD values <5.2 mm. In the multivariable analysis, the accuracy of the uMI–uTFD model was 74%, and its NPV was 90.24% (p = non-significant). Neither uMI nor uTFD were surrogates for overall and recurrence-free survivals in endometrial cancer. Conclusions: Both uMI and uTFD, either alone or in combination, were valuable tools for gaining additional preoperative information on expected lymph node status. Negative lymph nodes status was better described by ultrasound biomarkers than a positive status. It was easier to use the uTFD rather than the uMI measurement as a biomarker of EC invasion, and the former still maintained a similar predictive value for lymph node metastases to the latter at diagnosis.

Highlights

  • IntroductionEndometrial cancer (EC) is the most prevalent malignancy of the female genital tract among the top-ranked countries on the Human Development Index (HDI) and is creativecommons.org/licenses/by/ 4.0/)

  • The aim of the study was to test the predictive power of ultrasound biomarkers of uterine infiltration currently used to determine the risk of lymph node metastasis in endometrial cancer, taking into consideration endometrial cancer risk groupings and recurrence-free and overall survival

  • It should be noted that the above-mentioned ultrasound predictors are of greater value for indicating the absence of metastases, i.e., with ultrasoundmeasured myometrial invasion (uMI) < 50% and/or uTFD ≥ 5.2 mm, it can be said that there will be no metastasis with a higher level of confidence than indicated with uMI ≥ 50% and/or uTFD < 5.2 mm

Read more

Summary

Introduction

Endometrial cancer (EC) is the most prevalent malignancy of the female genital tract among the top-ranked countries on the Human Development Index (HDI) and is creativecommons.org/licenses/by/ 4.0/). In 2013, the European Society of Medical Oncology (ESMO) introduced three LNM risk groups: low, intermediate, and high [4]. A conference between the European Society of Medical Oncology (ESMO), the European Society of Radiotherapy and Oncology (ESTRO), and the European Society of Gynecologic Oncology (ESGO) established a consensus that there are five LNM risk groups: low, intermediate, high-intermediate, high, and advanced metastatic, highlighting the role of ultrasonography in the assessment of the biological behavior of tumors [5]. Ultrasonography, the most extensively used diagnostic method worldwide, meets one of the most common cancers in the world. Underscoring the importance of this method is the creation of a dictionary of changes in the endometrium and uterine cavity, created by the International Endometrial Tumor Analysis (IETA) and Morphological Uterus

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call